BioConsortia Appoints Nancy Vosnidou IP & Portfolio Strategist
b'As BioConsortia continues its discovery and development of powerful microbes with unique modes of action and innovates further into gene editing for microbial biopesticides and nitrogen fixation, we are pleased to announce that Nancy Vosnidou will join the BioConsortia team in the newly created position of IP & Portfolio Strategist.\nNancy brings deep experience in patent portfolio development and strategy, as well as competitive intelligence.
- b'As BioConsortia continues its discovery and development of powerful microbes with unique modes of action and innovates further into gene editing for microbial biopesticides and nitrogen fixation, we are pleased to announce that Nancy Vosnidou will join the BioConsortia team in the newly created position of IP & Portfolio Strategist.\nNancy brings deep experience in patent portfolio development and strategy, as well as competitive intelligence.
- Most recently, Nancy managed the CRISPR and molecular engineering IP portfolios for Corteva, a multinational ag tech company, with previous IP experience in pharmaceutical biologicals, ag microbials at a unicorn startup, and transgenic crop development with another of the big 5 agricultural companies.
- We have built a world-class team, which is doing great research, and we continue to move from strength to strength.
- Nancy is a very talented addition to this winning team,\xe2\x80\x9d said Marcus Meadows-Smith, CEO \xe2\x80\x93 BioConsortia, Inc..\nBioConsortia, Inc. is developing effective microbial solutions that enhance plant phenotypes and increase crop yields.